🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study of LVGN6051-201 is designed to use a bridging dose escalation to ...
Status
Completed
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2021-05-14
Trial ID
NCT04694781
Treatments Being Tested
LVGN7409 is a humanized monoclonal antibody that specifically binds to CD40...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2020-12-11
Trial ID
NCT04635995
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of LVGN6051 ...
Status
Active Not Recruiting
Location
Anhui Cancer Hospital
Start Date
2024-06-21
Trial ID
NCT06378177
Treatments Being Tested
LVGN6051 is a humanized monoclonal antibody that specifically binds to CD13...
Status
Completed
Location
University of California Irvine Health
Start Date
2019-10-31
Trial ID
NCT04130542
Treatments Being Tested
The purpose of this study is to asess the safety and tolerability and effic...
Status
Completed
Location
Henan cancer hospital
Start Date
2022-05-25
Trial ID
NCT05301764
Treatments Being Tested
This is an investigator-initiated industry-supported phase 1 clinical trial...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-11-12
Trial ID
NCT05075993